Current status and future prospective of immunointervention in multiple sclerosis

Area of Science:

• Neurology
• Immunology
• Neuroimmunology

Background:

• Multiple sclerosis (MS) is a central nervous system disorder involving inflammation and degeneration.
• Immune-modulating drugs are being investigated for MS treatment.
• Inflammation plays a dual role in MS, with some aspects aiding recovery.

Purpose of the Study:

• To review the current understanding of MS immunopathogenesis.
• To discuss the status of immunosuppression in MS treatment.
• To explore future therapeutic strategies for MS based on evolving knowledge.

Main Methods:

• Review of existing evidence from experimental models and MS patients.
• Analysis of clinical trial data for immunosuppressive and immunomodulatory therapies.
• Examination of the role of specific immune events in MS pathogenesis and treatment.

Main Results:

• Some immunosuppressive treatments have failed or worsened MS.
• Certain inflammatory processes are essential for acute damage control and regeneration.
• New treatments targeting specific immune pathways are being developed.

Conclusions:

• Understanding MS immunopathogenesis is critical for effective treatment.
• Future MS therapies should aim for targeted immune modulation, sparing general immunity.
• The evolving knowledge of MS offers new therapeutic avenues, including those tested in clinical trials.